Rocket Lab (RKLB) Stock Jumps 5% as Iridium Shareholders Greenlight $54 Merger

Key Takeaways

• On September 24, 2026, Iridium stockholders overwhelmingly backed Rocket Lab’s acquisition bid with 99.6% approval from votes cast.
• The special stockholder meeting saw participation from about 81% of Iridium’s total outstanding shares.
• Iridium stockholders will receive $54.00 per share in notional value through a combination of cash and Rocket Lab equity.
• RKLB shares surged 5% to $73.61 on the same day, bolstered by a Space Force contract announcement and fresh ARK Invest purchases.
• Final transaction completion is targeted for mid-2027, subject to regulatory clearance.

Shares of Rocket Lab (RKLB) advanced 5% during Thursday’s session, settling around $73.61 after reaching an intraday peak of $75.46. The rally coincided with a pivotal development in the company’s proposed takeover of satellite communications provider Iridium Communications (IRDM).

Rocket Lab USA, Inc., RKLB

During a special stockholder meeting held on September 24, Iridium investors overwhelmingly endorsed the proposed merger. Nearly 99.6% of ballots cast favored the transaction, with participation from approximately 81% of the company’s total outstanding equity.

In addition to the merger vote, stockholders approved an advisory measure regarding executive compensation arrangements tied to the deal. These approvals represent a significant step forward in completing the combination.

The transaction structure provides Iridium stockholders with $27.00 in cash per share alongside Rocket Lab stock, with the equity component determined through an exchange ratio featuring a collar mechanism. The combined consideration values each Iridium share at a notional $54.00.

Rocket Lab’s CEO Peter Beck characterized the approval as “an important milestone” toward creating what he termed a next-generation space industry leader. Iridium’s CEO Matt Desch shared similar enthusiasm, highlighting how the organizations’ strengths align.

Completion of the merger is anticipated around mid-2027, contingent upon receiving necessary regulatory approvals and satisfying standard closing requirements.

Additional Catalysts Behind RKLB’s Weekly Performance

Separate from the Iridium developments, Rocket Lab secured a position on the Space Force’s NITE-STAR contract platform. The vehicle carries a ceiling value approaching $981 million extending through 2036, though individual task order allocations remain uncertain.

ARK Invest added approximately $25 million in Rocket Lab positions across its portfolio this week. Fund manager Cathie Wood has accumulated shares on multiple occasions throughout the current year.

Market watchers also note a potential competitive advantage emerging from SpaceX’s reported plans to reduce third-party rideshare offerings, potentially redirecting demand toward alternative launch service providers like Rocket Lab.

Thursday’s session featured elevated trading activity. Volume reached nearly 25 million shares, representing an 8% increase compared to the typical daily average of 23.2 million shares.

Wall Street Maintains Divided Outlook

Analyst sentiment on Rocket Lab shows divergence. The stock holds a “Moderate Buy” consensus with an average price objective of $107.32, based on MarketBeat data.

Piper Sandler established a “neutral” stance with an $83.00 target during July. Stifel Nicolaus projected a more optimistic $132.00 target in June, whereas Wall Street Zen shifted to a “sell” recommendation in August.

Several market participants have raised questions about risks associated with the Iridium transaction. Areas of concern include capital requirements, execution challenges during integration, and valuation considerations for an already premium-priced stock.

Rocket Lab continues operating at a loss. The company reported a deficit of $0.08 per share in its most recent quarter, falling short of analyst projections, while revenue of $234.07 million exceeded consensus forecasts.

Insider activity has shown notable selling pressure. CEO Peter Beck divested more than 1.29 million shares during July for approximately $110 million, reducing his ownership position by roughly 32%.

Meanwhile, institutional investors are expanding their stakes. Andra AP fonden boosted its Rocket Lab position by over 2,500% during the second quarter.

Iridium shares edged up 1% following the stockholder vote announcement. The latest Wall Street rating on IRDM stands at “Hold” with a $54.00 price objective, aligning with the transaction’s notional valuation.